A study recently published in the Journal of Cardiovascular Electrophysiology has found that use of the Baylis Medical NRG® Transseptal Needle results in cost-savings per procedure, compared to use of a mechanical transseptal needle.
The study, entitled A Cost-Effectiveness Analysis Comparing a Conventional Mechanical Needle to a Radiofrequency Device for Transseptal Punctures, was led by Dr. Gregory Marcus at the University of California, San Francisco (UCSF).
According to the study, despite higher initial cost of the NRG needle, the total cost at 30 days post-procedure was lower when the NRG needle was used rather than a mechanical needle, when accounting for procedural and complication costs.
Additional cost savings were demonstrated by accounting for time saved in gaining transseptal access using the NRG needle, which uses radiofrequency energy to achieve transseptal puncture. This may enable faster catheterization lab turn-over and enhance efficiency of available space and personnel.
Read the full publication.
PRM-00618 EN J-1,2,3 V-1 © Baylis Medical Company Inc., 2020. NRG and the Baylis Medical logo are trademarks and/or registered trademarks of Baylis Medical Company Inc. in the USA and/or other countries. Other trademarks are property of their respective owners. CAUTION: Federal Law (USA) restricts the use of these devices to or by the order of a physician. Before use, consult product labels and Instructions for Use for Indications for Use, Contraindications, Warnings, Precautions, Adverse Events and Directions for Use.